American Century Companies’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
403,045
+302,639
| +301% | +$1.36M | ﹤0.01% | 2064 |
|
|
2025
Q1 | $466K | Buy |
100,406
+23,556
| +31% | +$109K | ﹤0.01% | 2533 |
|
|
2024
Q4 | $533K | Buy |
76,850
+16,485
| +27% | +$114K | ﹤0.01% | 2484 |
|
|
2024
Q3 | $320K | Buy |
60,365
+10,955
| +22% | +$58.1K | ﹤0.01% | 2617 |
|
|
2024
Q2 | $185K | Buy |
49,410
+15,562
| +46% | +$58.2K | ﹤0.01% | 2738 |
|
|
2024
Q1 | $239K | Buy |
33,848
+7,568
| +29% | +$53.4K | ﹤0.01% | 2723 |
|
|
2023
Q4 | $148K | Buy |
26,280
+6,466
| +33% | +$36.5K | ﹤0.01% | 2755 |
|
|
2023
Q3 | $94.9K | Buy |
19,814
+6,879
| +53% | +$33K | ﹤0.01% | 2725 |
|
|
2023
Q2 | $88.6K | Buy |
+12,935
| New | +$88.6K | ﹤0.01% | 2701 |
|